Fulcrum Therapeutics
FULC
#7805
Rank
โ‚ฌ0.21 B
Marketcap
3,42ย โ‚ฌ
Share price
0.00%
Change (1 day)
5.50%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2023 (TTM): -1,71ย โ‚ฌ

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is -1,69ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,33ย โ‚ฌ a decrease over its 2021 EPS that were of -2,15ย โ‚ฌ.

EPS history for Fulcrum Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,71ย โ‚ฌ-26.68%
2022-2,33ย โ‚ฌ8.3%
2021-2,15ย โ‚ฌ-18.51%
2020-2,64ย โ‚ฌ-31.36%
2019-3,85ย โ‚ฌ77.16%
2018-2,17ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,05ย โ‚ฌ 21.11%๐Ÿ‡บ๐Ÿ‡ธ USA